论文部分内容阅读
急性冠状动脉综合征(ACS)包括不稳定心绞痛(UA)、非ST段抬高性急性心肌梗死(NSTEAM I)和ST段抬高性急性心肌梗死(STEAM I)。近20年来,β受体阻滞剂使心肌梗死(AM I)的疗效显著提高[1]。笔者用静脉注射β受体阻滞剂治疗急性冠状动脉综合征103例,其中53例接受贝他乐克静脉注射+抗
Acute coronary syndromes (ACS) include unstable angina (UA), non-ST-segment elevation acute myocardial infarction (NSTEAM I) and ST-segment elevation acute myocardial infarction (STEAM I). In the past 20 years, β-blockers have significantly improved the efficacy of myocardial infarction (AMI) [1]. I used intravenous beta blockers in the treatment of 103 cases of acute coronary syndromes, of which 53 cases received intravenous injection of Betaloc